Information Journal Paper
APA:
Copy. (2018). Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study. Lancet Haematology, 5(5), 220-231. SID. https://sid.ir/paper/758184/en
Vancouver:
Copy. Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study. Lancet Haematology[Internet]. 2018;5(5):220-231. Available from: https://sid.ir/paper/758184/en
IEEE:
Copy, “Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study,” Lancet Haematology, vol. 5, no. 5, pp. 220–231, 2018, [Online]. Available: https://sid.ir/paper/758184/en